[ad_1]
Due to cases of thrombosis following the use of the AstraZeneca coronavirus vaccine, the Netherlands has decided not to vaccinate citizens under 60 years of age with this drug for the time being.
The Dutch Ministry of Health has decided to discontinue vaccination with AstraZeneca for people under 60 years of age. This was announced on April 2 by the country’s government.
“The immediate reason for this decision is the new case reports of extensive thrombosis combined with low platelet counts after vaccination with the AstraZeneca vaccine,” he said.
The department emphasized that five of those cases have already been confirmed in the country among women between the ages of 25 and 65.
As of April 2, around 400,000 AstraZeneca injections had been injected in the Netherlands, the government added.
Germany and Canada have already made similar decisions this week.
According to the European Medicines Agency, clinical studies of the AstraZeneca coronavirus vaccine have shown that it is effective in preventing COVID-19 in people over 18 years of age. The vaccine was initially set at around 60%, but in March AstraZeneca updated its study and raised the effectiveness to 76%.
More than 10 countries have announced the suspension of the use of the AstraZeneca coronavirus vaccine or its individual batches. In some countries, there have been reports of cases of thrombosis in patients who received the vaccine. Other states have stated that no such cases have been recorded, but they are suspending vaccination with this drug as a precautionary measure.
The EMA’s Pharmacovigilance Risk Committee noted on March 18 that the benefits of the AstraZeneca vaccine in fighting coronavirus infection still outweigh the risks. These conclusions were drawn after completing a preliminary review of reports of blood clots in people vaccinated with the AstraZeneca vaccine.
A similar statement was made on March 18 at the British Agency for the Regulation of Medicines and Medical Devices, and on March 19 at the World Health Organization. Since then, countries have begun resuming vaccination with AstraZeneca.
[ad_2]
